The S&P 500 Index is hitting all-time highs and we are now deep into earnings season. This week will mark the second week of the earnings floodgates being open. 24/7 Wall St. has decided to offer an earnings preview cheat sheet for readers for what it deems the top remaining earnings for the week ahead.
Estimates have been compiled from Thomson Reuters for consensus earnings per share (EPS) and revenues, as well as for the consensus analyst price target calculated on a mean basis. We have also added in color on each, but due to Washington’s closure and there being three weeks in the dark, we have not included guidance for the fourth quarter of 2013 nor any preliminary 2014 outlooks.
Be advised that some of these estimates almost certainly will change, especially for those companies reporting later in the week. These are the top 14 earnings remaining for the week ahead. Oil names are included in a separate preview, although J.P. Morgan just forecast strong integrated oil earnings reports.
Netflix Inc. (NASDAQ: NFLX) is set to report Monday after the close. This is becoming the largest alternative media player that made it to mainstream. Shares closed at $333.50 on Friday, and the consensus price target is all the way down at about $250. Netflix now has a $20 billion market cap. As of Monday morning, this stock traded at more than 200-times expected 2013 earnings and 100-times expected 2014 earnings. Analysts have the Netflix consensus estimates as $0.49 earnings per share (EPS) and $1.1 billion in revenue. Netflix recently guided subscriber growth to 30.5 million to 31.3 million total and 29.4 million to 30.1 million paid for this past quarter.
DuPont, or E.I. du Pont de Nemours & Co. (NYSE: DD), reports Tuesday morning. This was surprising to see on the list of the best-performing DJIA stocks of 2013. That means the bar has to be set high. At $59.62 as of Friday’s closing bell, its consensus price target is about $1 less than the current price. DuPont’s consensus estimates are $0.41 EPS and $7.78 billion in revenue.
Amgen Inc. (NASDAQ: AMGN) reports after the close on Tuesday, and this could easily set the tone for how biotech stocks will get treated in the next two weeks when they report earnings. At $114.92 as of Friday’s close, its consensus price target is $115.68. This sector has outperformed handily in 2013, so watch closely. Amgen’s consensus earnings estimates are $1.79 per share on $4.6 billion in revenue.